Skip to main content
. Author manuscript; available in PMC: 2020 Sep 29.
Published in final edited form as: Eur J Surg Oncol. 2019 Feb 18;45(8):1417–1424. doi: 10.1016/j.ejso.2019.02.019

Table 3.

Independent prognostic factors in pathological stage IIB cervical cancer.

Characteristics Disease-free survival
Cause-specific survival
Adjusted-HR (95%CI) P-value Adjusted-HR (95%CI) P-value
Age (years)
 ≥50 1 1
 <50 1.567 (1.125–2.181) 0.008 2.166 (1.454–3.224) <0.001
Histology
 SCC 1 1
 Non-SCC 2.205 (1.587–3.064) <0.001 2.139 (1.446–3.163) <0.001
Pelvic lymph node <0.001a <0.001a
 Not involved 1 1
 Single metastasis 1.234 (0.720–2.113) 0.445 1.013 (0.482–2.128) 0.974
 Multiple metastasis 2.535 (1.726–3.725) <0.001 2.725 (1.686–4.404) <0.001
 Missing - - - -
Para-aortic lymph node 0.004a 0.012a
 Not involved 1 1
 Single metastasis 1.422 (0.654–3.090) 0.375 1.647 (0.690–3.932) 0.261
 Multiple metastasis 2.428 (1.286–4.584) 0.006 2.466 (1.163–5.228) 0.019
 Clinically not involved 0.909 (0.594–1.391) 0.660 0.913 (0.535–1.556) 0.737

Cox proportional hazard regression models for multivariate analysis (conditional backward). Only significant covariates (P < 0.05) in the final models were shown in the table.

a

P-value for interaction. – suppressed due to number <5. Abbreviations: HR, hazard ratio; CI, confidence interval; SCC, squamous cell carcinoma; Adeno, adenocarcinoma; AS, adenosquamous; DSI, deep stromal invasion; LVSI, lympho-vascular space invasion; RT, whole pelvic radiotherapy; CCRT, concurrent chemo-radiotherapy.